Developer of behavior change technology designed to end the stress and burnout epidemic.
Developer of behavior change technology designed to end the stress and burnout epidemic.
Other Healthcare Technology Systems📍 New York, NYFounded 2016
Current Valuation
$700M
as of 2021-Q3
PRIVATE
QL Price
$700M
0% vs last round
QuantLogix's current estimate for Thrive Global, published 2026-09-27 — in line with the last disclosed round of $700M (2021-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$700M
2021-Q3
weight 0.03
Secondary market print
$700M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Thrive Global since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Thrive Global, 2026-09-27 (5db22e9321be82c3).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Thrive Global going public?
No. Thrive Global is private and has not filed to go public. There is no S-1 on file.
What is Thrive Global's valuation in 2026?
Thrive Global is valued at $700M as of 2021-Q3, set by its Series C ($80M, Jul 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Thrive Global filed an S-1?
No public S-1 is on file for Thrive Global.
How much has Thrive Global raised?
Thrive Global has raised $155M in total, most recently a Series C of $80M in Jul 2021.
Is Thrive Global publicly traded — can you buy Thrive Global stock?
No. Thrive Global is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Thrive Global on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2016
HQ
New York, NY
Employees
859
Total Raised
$155M
Last Round
Series C — $80M (Jul 2021)
IPO Status
private
Fundraising Status
Series C · $80M · 5y 2mo ago
privateTotal raised $155M
Secondary Market
Implied price / share
$0.5
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. The feed’s last-round price for this company is not a plausible per-share figure, so no comparison is shown. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$80M
Jul 2021
—
$700M
Talent Signal
Hiring trend
▶ Hiring steady
+8% vs 2026-08
Open roles
14
via careers page
Product-build share
29%
engineering, research, product, design
Trajectory
strengthening
balanced build + GTM — 29% builders vs 71% go-to-market/G&A — scaling both sides.
Recent senior hire: 1 senior hire (CEO).
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INMarin TchakarovCEO · 2026-08-17
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
![notes-medical iconnotes-medical iconLead Data AnalystThrive Product UIThrive for Support Teams\\ ![Health Writer & Content Creator
Counted from Thrive Global's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q3. Refreshed quarterly.